Hemp/CBD and other cannabis startups share in equity deal count quarterly 2018-2019

Published by
Matej Mikulic,
Sep 8, 2020
In the second quarter of 2019, startups focusing on hemp and cannabidiol accounted for 25 percent of the number of equity deals including cannabis startups. The statistic illustrates the share of the global equity deal count including cannabis startups from 1st quarter 2014 to 2nd quarter 2019, by type/focus. Hemp-derived cannabidiol (CBD) is among the most promising compounds of cannabis. CBD has no psychoactive effects and could possibly be used in the treatment of anxiety, cognition, movement disorders, and pain.

Distribution of the global equity deal count including cannabis startups from Q1 2014 to Q2 2019, by type

Loading statistic...

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

July 2019

Region

Worldwide

Survey time period

1st quarter 2014 to 2nd quarter 2019

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interest

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Medical cannabis in the United Kingdom (UK) "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Medical cannabis in the United Kingdom (UK)

Market overview

8

General use

4

Illegal use for medical reasons

4

Legal medical use

5

Cannabidiol

3

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Medical cannabis in the UKMedical cannabis in the U.S.Medical cannabis in CanadaDrug situation in EuropeRecreational cannabis in Canada
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interest

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.
Menu